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ABSTRACT 
Molecular alterations in PIK3CA oncogene that encodes the p110α catalytic subunit of 
phosphatidylinositol 3-kinase (PI3K p110α) are commonly found in human cancers. In this 
study, we examined the expression of PI3K p110α and PIK3CA gene amplification in 74 
nasopharyngeal carcinoma (NPC) cases. Immunohistochemical staining demonstrated 
overexpression of PI3K p110α protein in 44.6 % (33/74) of NPCs and 4.8 % (2/42) of the 
adjacent normal nasopharyngeal mucosa. Copy number of PIK3CA gene was successfully 
analyzed in 51 of the total NPC cases and 19 non-malignant nasopharynx tissues by 
quantitative real-time PCR. Using mean + 2(standard deviation) of copy numbers in the non-
malignant nasopharynx tissues as a cutoff value, PIK3CA copy number gain was found in 10 
of 51 (19.6 %) NPC cases. High PI3K p110α expression level was correlated with increased 
PIK3CA copy number (Spearman’s rho =0.324, P = 0.02). PI3K p110α expression and 
PIK3CA copy number did not associate with Akt phosphorylation, and patient and tumor 
variables. This study suggests that PI3K p110α overexpression, which is attributed, at least in 
part, to PIK3CA gene amplification, may contribute to NPC pathogenesis. However, these 
molecular aberrations may not be responsible for activation of Akt signaling in NPC. 
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